SPL Set ID: 30077f79-341f-4618-9ec5-23b17b212fae

1 drug(s) with this SPL Set ID

Open DailyMed details

Docetaxel DOCETAXEL ANHYDROUS
SAGENT PHARMACEUTICALS FDA Rx Only

Docetaxel is an antineoplastic agent belonging to the taxoid family. It is prepared by semisynthesis beginning with a precursor extracted from the renewable needle biomass of yew plants. The chemical name for docetaxel is (2R,3S)-N-carboxy-3-phenylisoserine,N- tert -butyl ester, 13-ester with 5β-20-epoxy-1,2α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4-acetate 2-benzoate, trihydrate. Docetaxel has the following structural formula: Docetaxel is a white to almost-white powder with an empirical formula of C 43 H 53 NO 14 •3H 2 O, and a molecular weight of 861.9. It is highly lipophilic and practically insoluble in water. Structural Formula One-vial Formulation Docetaxel Injection, USP Docetaxel Injection, USP is a sterile, non-pyrogenic, pale-yellow to brownish-yellow solution at 20 mg per mL concentration. Each mL contains 20 mg docetaxel (anhydrous) in 0.54 grams polysorbate 80 and 0.395 grams dehydrated alcohol (50% v/v) solution, with anhydrous citric acid for pH adjustment. Docetaxel Injection, USP is available in single-dose vials containing 20 mg (1 mL) or 80 mg (4 mL) docetaxel (anhydrous). Docetaxel Injection, USP requires NO prior dilution with a diluent and is ready to add to the infusion solution.

← Back to search